Pharmacovigilance-related recommendations to product information for centrally authorised veterinary medicines
Start of Union reviews adopted during the CHMP meeting of 19-22 February 2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2024
Summary of opinion: Carvykti, 22/02/2024
Summary of opinion: Xromi, 22/02/2024 Positive
Summary of opinion: Cibinqo, 22/02/2024 Positive
Summary of opinion: Reblozyl, 22/02/2024 Positive
New treatment for rare motor neurone disease recommended for approval
First oral treatment against residual haemolytic anaemia in patients with paroxysmal nocturnal haemoglobinuria
Committee for Medicinal Products for Veterinary Use (CVMP): 16-18 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 16 January 2024 to 18 January 2024